U.S. flag

An official website of the United States government

nsv7093597

  • Variant Calls:1
  • Validation:Not tested
  • Clinical Assertions: Yes
  • Region Size:1

Genome View

Select assembly:
Overlapping variant regions from other studies: 142 SVs from 33 studies. See in: genome view    
Submitted genomic31,223,446-31,223,446Question Mark
Overlapping variant regions from other studies: 142 SVs from 33 studies. See in: genome view    
Submitted genomic29,550,464-29,550,464Question Mark

Variant Region Placement Information

Variant Region IDPlacement TypeAssemblyAssembly UnitSequence IDChrStartStop
nsv7093597Submitted genomicGRCh38 (hg38)Primary AssemblyNC_000017.11Chr1731,223,44631,223,446
nsv7093597Submitted genomicGRCh37 (hg19)Primary AssemblyNC_000017.10Chr1729,550,46429,550,464

Variant Call Information

Variant Call IDTypeMethodAnalysisSubject PhenotypeClinical InterpretationSource of InterpretationClinVar ID
nssv18786558insertionMultipleMultipleNEUROFIBROMATOSIS, TYPE I; NF1; Neurofibromatosis 1; Neurofibromatosis type 1; Neurofibromatosis, type 1; See individual phenotypes in OMIM allelic variantsPathogenicClinVarRCV003013131.1, VCV002090493.1

Variant Call Placement Information

Variant Call IDPlacement TypeHGVSAssemblySequence IDChrStartStop
nssv18786558Submitted genomicNC_000017.11:g.312
23446_31223447ins1
15
GRCh38 (hg38)NC_000017.11Chr1731,223,44631,223,446
nssv18786558Submitted genomicNC_000017.10:g.295
50464_29550465ins1
15
GRCh37 (hg19)NC_000017.10Chr1729,550,46429,550,464

No validation data were submitted for this variant

Clinical Assertions

Variant Call IDHGVSTypeAllele OriginSubject PhenotypeClinical InterpretationSource of InterpretationClinVar ID
nssv18786558GRCh37: NC_000017.10:g.29550464_29550465ins115, GRCh38: NC_000017.11:g.31223446_31223447ins115insertiongermlineNEUROFIBROMATOSIS, TYPE I; NF1; Neurofibromatosis 1; Neurofibromatosis type 1; Neurofibromatosis, type 1; See individual phenotypes in OMIM allelic variantsPathogenicClinVarRCV003013131.1, VCV002090493.1

No genotype data were submitted for this variant

Support Center